What are the Key Components of the European Partnership?
The EPPM consists of several key components aimed at fostering innovation and collaboration in personalised medicine: 1. Research and Development: Supporting research initiatives to discover new biomarkers and develop novel therapies. 2. Clinical Trials: Enhancing the design and implementation of clinical trials to evaluate personalised treatments. 3. Data Sharing: Facilitating the sharing of genomic and clinical data across borders to improve patient outcomes. 4. Education and Training: Providing resources and training to healthcare professionals on the principles and practice of personalised medicine. 5. Regulatory Framework: Establishing guidelines and policies to ensure the safe and effective implementation of personalised therapies.
